Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Azam Daraei"'
Autor:
Havva Afshari, Shokoofe Noori, Mitra Nourbakhsh, Azam Daraei, Mahsa Azami Movahed, Afshin Zarghi
Publikováno v:
BioImpacts, Vol 14, Iss 2, Pp 27618-27618 (2024)
Introduction: Imidazo[1,2-a]pyridine derivatives with diverse pharmacological properties and curcumin, as a potential natural anti-inflammatory compound, are promising compounds for cancer treatment. This study aimed to synthesize a novel imidazo[1,2
Externí odkaz:
https://doaj.org/article/08bdb5e6a1714375a134e4ef524deb2a
Prostate cancer (PCa) was known as the second most common cancer in men. Although there were several approaches to treat this disease, the cost and side effects of some approaches have encountered the patients with challenges. Therefore, the design o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6ddb5442aee0704d7163071164635e2
https://doi.org/10.21203/rs.3.rs-2747024/v1
https://doi.org/10.21203/rs.3.rs-2747024/v1
Autor:
Sajad, Rafiee, Masoumeh, Rajabibazl, Reza, Meshkani, Azam, Daraei, Mehryar, Zargari, Fahimeh, Sharafeddin, Zahra, Fazeli, Attabak, Toffani Milani, Maryam, Taherkhani
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Warfarin is a vitamin K antagonist that genetic and non-genetic factors affected on its dose requirement in the patients with cardio vascular disease. The aim of this study was whether the APOE and VKORC1 polymorphisms influence on warfarin dose requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::267e29e4911200342b0235431a19ded9
https://pubmed.ncbi.nlm.nih.gov/29201112
https://pubmed.ncbi.nlm.nih.gov/29201112
Autor:
Saeideh Foroumadi, Maral Yarahmadi, Masoumeh Rajabibazl, Walead Ebrahimizadeh, Solmaz Shahidi, Azam Daraei, Shirin Rajabi, Azam Rahimpour
Publikováno v:
In vitro cellulardevelopmental biology. Animal. 54(2)
Breast cancer with more than 1.7 million diagnoses per year has been known as one of the most prevalent cancers among women worldwide. Despite the availability of advanced treatment options, cancer progression and metastasis is observed in 20% of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ebe1b474c068736073d6ff2e3caf178
https://pubmed.ncbi.nlm.nih.gov/29305748
https://pubmed.ncbi.nlm.nih.gov/29305748